Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital‐based case–control study

This publication has 16 references indexed in Scilit:

• Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies
  Journal of Thrombosis and Haemostasis, 2005
• Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal investigation of thromboembolism etiology (LITE)
  American Journal of Hematology, 2003
• Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study
  The Lancet, 2002
• Incidence of Venous Thromboembolism: A Community-based Study in Western France
  Thrombosis and Haemostasis, 2000
• Venous thrombosis: a multicausal disease
  The Lancet, 1999
• Vitamin Supplementation Reduces Blood Homocysteine Levels
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
  Circulation, 1997
• Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
  New England Journal of Medicine, 1996
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993